In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover safe dosing program. Further members will probably be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section C, https://hectorvitdo.p2blogs.com/31089127/the-2-minute-rule-for-is-abbv-744-effective-for-hematologic-cancers